{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:07:20Z","timestamp":1787854040279,"version":"build-2784847793"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["0134-00123B"],"award-info":[{"award-number":["0134-00123B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011054","name":"Ministry of Foreign Affairs of Denmark | Danish International Development Agency","doi-asserted-by":"publisher","award":["17-02-KU"],"award-info":[{"award-number":["17-02-KU"]}],"id":[{"id":"10.13039\/501100011054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009425","name":"Landsteiner Foundation for Blood Transfusion Research","doi-asserted-by":"publisher","award":["1721"],"award-info":[{"award-number":["1721"]}],"id":[{"id":"10.13039\/100009425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001731","name":"Danida Fellowship Centre","doi-asserted-by":"publisher","award":["BSU3-UG"],"award-info":[{"award-number":["BSU3-UG"]}],"id":[{"id":"10.13039\/501100001731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-55543-w","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T21:02:20Z","timestamp":1735851740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9876-0248","authenticated-orcid":false,"given":"Mary","family":"Lopez-Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8017-2491","authenticated-orcid":false,"given":"Zakaria","family":"Seidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1985-5901","authenticated-orcid":false,"given":"Mads Delbo","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Nouta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-4995","authenticated-orcid":false,"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-003X","authenticated-orcid":false,"given":"Gestur","family":"Vidarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Ofori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1698-4927","authenticated-orcid":false,"given":"Lars","family":"Hviid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"55543_CR1","unstructured":"WHO. World Malaria Report. (2023)."},{"key":"55543_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/tmi.12313_2","volume":"19","author":"WHO.","year":"2014","unstructured":"WHO. Severe malaria. Trop. Med. Int. Health. 19, 7\u2013131 (2014).","journal-title":"Trop. Med. Int. Health."},{"key":"55543_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/bs.apar.2015.02.004","volume":"88","author":"L Hviid","year":"2015","unstructured":"Hviid, L. & Jensen, A. T. PfEMP1 - A parasite protein family of key importance in Plasmodium falciparum malaria immunity and pathogenesis. Adv. Parasitol. 88, 51\u201384 (2015).","journal-title":"Adv. Parasitol."},{"key":"55543_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.apar.2024.02.001","volume":"125","author":"L Hviid","year":"2024","unstructured":"Hviid, L., Jensen, A. R. & Deitsch, K. W. PfEMP1 and var genes - Still of key importance in Plasmodium falciparum malaria pathogenesis and immunity. Adv. Parasitol. 125, 53\u2013103 (2024).","journal-title":"Adv. Parasitol."},{"key":"55543_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/192733a0","volume":"192","author":"S Cohen","year":"1961","unstructured":"Cohen, S., Mc, G. I. & Carrington, S. Gamma-globulin and acquired immunity to human malaria. Nature 192, 733\u2013737 (1961).","journal-title":"Nature"},{"key":"55543_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1126\/science.2417315","volume":"231","author":"K Marsh","year":"1986","unstructured":"Marsh, K. & Howard, R. J. Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science 231, 150\u2013153 (1986).","journal-title":"Science"},{"key":"55543_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nm0398-358","volume":"4","author":"PC Bull","year":"1998","unstructured":"Bull, P. C. et al. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat. Med. 4, 358\u2013360 (1998).","journal-title":"Nat. Med."},{"key":"55543_CR8","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1172\/JCI62182","volume":"122","author":"JA Chan","year":"2012","unstructured":"Chan, J. A. et al. Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity. J. Clin. Invest. 122, 3227\u20133238 (2012).","journal-title":"J. Clin. Invest."},{"key":"55543_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.chom.2019.10.012","volume":"26","author":"SK Tessema","year":"2019","unstructured":"Tessema, S. K. et al. Protective immunity against severe malaria in children is associated with a limited repertoire of antibodies to conserved PfEMP1 variants. Cell Host Microbe 26, 579\u2013590.e575 (2019).","journal-title":"Cell Host Microbe"},{"key":"55543_CR10","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1128\/IAI.00593-10","volume":"78","author":"GK Cham","year":"2010","unstructured":"Cham, G. K. et al. Hierarchical, domain type-specific acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 in Tanzanian children. Infect. Immun. 78, 4653\u20134659 (2010).","journal-title":"Infect. Immun."},{"key":"55543_CR11","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1084\/jem.20041579","volume":"200","author":"A Salanti","year":"2004","unstructured":"Salanti, A. et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J. Exp. Med. 200, 1197\u20131203 (2004).","journal-title":"J. Exp. Med."},{"key":"55543_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/76272","volume":"6","author":"DJ Conway","year":"2000","unstructured":"Conway, D. J. et al. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat. Med. 6, 689\u2013692 (2000).","journal-title":"Nat. Med."},{"key":"55543_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1615","volume":"2","author":"AD Douglas","year":"2011","unstructured":"Douglas, A. D. et al. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat. Commun. 2, 601 (2011).","journal-title":"Nat. Commun."},{"key":"55543_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-361","volume":"11","author":"E Villasis","year":"2012","unstructured":"Villasis, E. et al. Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru. Malar. J. 11, 361 (2012).","journal-title":"Malar. J."},{"key":"55543_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/infdis\/jiw617","volume":"215","author":"IH Kana","year":"2017","unstructured":"Kana, I. H. et al. Naturally acquired antibodies target the glutamate-rich protein on intact merozoites and predict protection against febrile malaria. J. Infect. Dis. 215, 623\u2013630 (2017).","journal-title":"J. Infect. Dis."},{"key":"55543_CR16","doi-asserted-by":"publisher","first-page":"e16414","DOI":"10.1371\/journal.pone.0016414","volume":"6","author":"A Ghumra","year":"2011","unstructured":"Ghumra, A. et al. Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum. PLoS ONE 6, e16414 (2011).","journal-title":"PLoS ONE"},{"key":"55543_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/infdis\/jiad438","volume":"229","author":"AV Oleinikov","year":"2024","unstructured":"Oleinikov, A. V. et al. Profiling the Plasmodium falciparum erythrocyte membrane protein 1-specific immunoglobulin G response among Ghanaian children with hemoglobin S and C. J. Infect. Dis. 229, 203\u2013213 (2024).","journal-title":"J. Infect. Dis."},{"key":"55543_CR18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/infdis\/jiy580","volume":"219","author":"JA Chan","year":"2019","unstructured":"Chan, J. A. et al. Antibody targets on the surface of Plasmodium falciparum-infected erythrocytes that are associated with immunity to severe malaria in young children. J. Infect. Dis. 219, 819\u2013828 (2019).","journal-title":"J. Infect. Dis."},{"key":"55543_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16305-0","volume":"12","author":"J Suurbaar","year":"2022","unstructured":"Suurbaar, J. et al. ICAM-1-binding Plasmodium falciparum erythrocyte membrane protein 1 variants elicits opsonic-phagocytosis IgG responses in Beninese children. Sci. Rep. 12, 12994 (2022).","journal-title":"Sci. Rep."},{"key":"55543_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.36806","volume":"7","author":"G Arora","year":"2018","unstructured":"Arora, G. et al. NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity. Elife 7, e36806 (2018).","journal-title":"Elife"},{"key":"55543_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26118-w","volume":"12","author":"MD Larsen","year":"2021","unstructured":"Larsen, M. D. et al. Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination. Nat. Commun. 12, 5838 (2021).","journal-title":"Nat. Commun."},{"key":"55543_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add9012","volume":"15","author":"M Ty","year":"2023","unstructured":"Ty, M. et al. Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malaria. Sci. Transl. Med. 15, eadd9012 (2023).","journal-title":"Sci. Transl. Med."},{"key":"55543_CR23","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/s41590-023-01544-8","volume":"24","author":"F Nimmerjahn","year":"2023","unstructured":"Nimmerjahn, F., Vidarsson, G. & Cragg, M. S. Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy. Nat. Immunol. 24, 1244\u20131255 (2023).","journal-title":"Nat. Immunol."},{"key":"55543_CR24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1021\/pr300887z","volume":"12","author":"MP Bakovic","year":"2013","unstructured":"Bakovic, M. P. et al. High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. J. Proteome Res. 12, 821\u2013831 (2013).","journal-title":"J. Proteome Res."},{"key":"55543_CR25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jprot.2011.11.003","volume":"75","author":"MH Selman","year":"2012","unstructured":"Selman, M. H. et al. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface. J. Proteom. 75, 1318\u20131329 (2012).","journal-title":"J. Proteom."},{"key":"55543_CR26","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.it.2022.08.001","volume":"43","author":"JJ Oosterhoff","year":"2022","unstructured":"Oosterhoff, J. J., Larsen, M. D., van der Schoot, C. E. & Vidarsson, G. Afucosylated IgG responses in humans - structural clues to the regulation of humoral immunity. Trends Immunol. 43, 800\u2013814 (2022).","journal-title":"Trends Immunol."},{"key":"55543_CR27","doi-asserted-by":"publisher","first-page":"26733","DOI":"10.1074\/jbc.M202069200","volume":"277","author":"RL Shields","year":"2002","unstructured":"Shields, R. L. et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fc\u03b3RIII and antibody-dependent cellular toxicity. J. Biol. Chem. 277, 26733\u201326740 (2002).","journal-title":"J. Biol. Chem."},{"key":"55543_CR28","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3389\/fimmu.2017.00877","volume":"8","author":"G Dekkers","year":"2017","unstructured":"Dekkers, G. et al. Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities. Front. Immunol. 8, 877 (2017).","journal-title":"Front. Immunol."},{"key":"55543_CR29","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.4049\/jimmunol.2100399","volume":"207","author":"TLJ van Osch","year":"2021","unstructured":"van Osch, T. L. J. et al. Fc galactosylation promotes hexamerization of human IgG1, leading to enhanced classical complement activation. J. Immunol. 207, 1545\u20131554 (2021).","journal-title":"J. Immunol."},{"key":"55543_CR30","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1172\/JCI65708","volume":"123","author":"ME Ackerman","year":"2013","unstructured":"Ackerman, M. E. et al. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J. Clin. Invest. 123, 2183\u20132192 (2013).","journal-title":"J. Clin. Invest."},{"key":"55543_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1126\/science.aai8128","volume":"355","author":"TT Wang","year":"2017","unstructured":"Wang, T. T. et al. IgG antibodies to dengue enhanced for Fc\u03b3RIIIA binding determine disease severity. Science 355, 395\u2013398 (2017).","journal-title":"Science"},{"key":"55543_CR32","doi-asserted-by":"publisher","first-page":"eabc8378","DOI":"10.1126\/science.abc8378","volume":"371","author":"MD Larsen","year":"2021","unstructured":"Larsen, M. D. et al. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science 371, eabc8378 (2021).","journal-title":"Science"},{"key":"55543_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.parepi.2023.e00317","volume":"22","author":"Z Seidu","year":"2023","unstructured":"Seidu, Z. et al. Plasmodium falciparum infection and naturally acquired immunity to malaria antigens among Ghanaian children in northern Ghana. Parasite Epidemiol. Control 22, e00317 (2023).","journal-title":"Parasite Epidemiol. Control"},{"key":"55543_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0166-6851(91)90135-S","volume":"49","author":"MB Borre","year":"1991","unstructured":"Borre, M. B. et al. Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate lifecycle. Mol. Biochem. Parasitol. 49, 119\u2013132 (1991).","journal-title":"Mol. Biochem. Parasitol."},{"key":"55543_CR35","doi-asserted-by":"publisher","first-page":"e1002665","DOI":"10.1371\/journal.ppat.1002665","volume":"8","author":"A Ghumra","year":"2012","unstructured":"Ghumra, A. et al. Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites. PLoS Pathog. 8, e1002665 (2012).","journal-title":"PLoS Pathog."},{"key":"55543_CR36","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1128\/IAI.73.7.4112-4118.2005","volume":"73","author":"R Megnekou","year":"2005","unstructured":"Megnekou, R., Staalsoe, T., Taylor, D. W., Leke, R. & Hviid, L. Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens. Infect. Immun. 73, 4112\u20134118 (2005).","journal-title":"Infect. Immun."},{"key":"55543_CR37","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1046\/j.1365-2370.2001.00254.x","volume":"28","author":"BY Loveslati","year":"2001","unstructured":"Loveslati, B. Y. et al. A study of Gm allotypes and immunoglobulin heavy gamma IGHG genes in Berbers, Arabs and sub-Saharan Africans from Jerba Island, Tunisia. Eur. J. Immunogenet. 28, 531\u2013538 (2001).","journal-title":"Eur. J. Immunogenet."},{"key":"55543_CR38","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1002\/pmic.200700289","volume":"7","author":"M Wuhrer","year":"2007","unstructured":"Wuhrer, M. et al. Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics 7, 4070\u20134081 (2007).","journal-title":"Proteomics"},{"key":"55543_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.pt.2015.04.009","volume":"31","author":"CW Wang","year":"2015","unstructured":"Wang, C. W. & Hviid, L. Rifins, rosetting, and red blood cells. Trends Parasitol. 31, 285\u2013286 (2015).","journal-title":"Trends Parasitol."},{"key":"55543_CR40","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4269\/ajtmh.2009.09-0406","volume":"81","author":"OK Doumbo","year":"2009","unstructured":"Doumbo, O. K. et al. High levels of Plasmodium falciparum rosetting in all clinical forms of severe malaria in African children. Am. J. Trop. Med. Hyg. 81, 987\u2013993 (2009).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"55543_CR41","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/0140-6736(90)93174-N","volume":"336","author":"J Carlson","year":"1990","unstructured":"Carlson, J. et al. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336, 1457\u20131460 (1990).","journal-title":"Lancet"},{"key":"55543_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02061-x","volume":"19","author":"DH Opi","year":"2021","unstructured":"Opi, D. H. et al. Reduced risk of placental parasitemia associated with complement fixation on Plasmodium falciparum by antibodies among pregnant women. BMC Med. 19, 201 (2021).","journal-title":"BMC Med."},{"key":"55543_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1467-6","volume":"18","author":"JC Cutts","year":"2020","unstructured":"Cutts, J. C. et al. Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review. BMC Med. 18, 14 (2020).","journal-title":"BMC Med."},{"key":"55543_CR44","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65776","volume":"10","author":"EH Aitken","year":"2021","unstructured":"Aitken, E. H. et al. Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malaria. Elife 10, e65776 (2021).","journal-title":"Elife"},{"key":"55543_CR45","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0022-2836(02)01250-0","volume":"325","author":"S Krapp","year":"2003","unstructured":"Krapp, S., Mimura, Y., Jefferis, R., Huber, R. & Sondermann, P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J. Mol. Biol. 325, 979\u2013989 (2003).","journal-title":"J. Mol. Biol."},{"key":"55543_CR46","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1021\/acs.jproteome.6b00038","volume":"15","author":"N de Haan","year":"2016","unstructured":"de Haan, N., Reiding, K. R., Driessen, G., van der Burg, M. & Wuhrer, M. Changes in healthy human IgG Fc-glycosylation after birth and during early childhood. J. Proteome Res. 15, 1853\u20131861 (2016).","journal-title":"J. Proteome Res."},{"key":"55543_CR47","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/bjh.12965","volume":"166","author":"R Kapur","year":"2014","unstructured":"Kapur, R. et al. Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn. Br. J. Haematol. 166, 936\u2013945 (2014).","journal-title":"Br. J. Haematol."},{"key":"55543_CR48","doi-asserted-by":"publisher","first-page":"jiae529","DOI":"10.1093\/infdis\/jiae529","volume":"25","author":"M Lopez-Perez","year":"2024","unstructured":"Lopez-Perez, M. et al. Fc-afucosylation of VAR2CSA-specific immunoglobulin G and clinical immunity to placental Plasmodium falciparum malaria. J. Infect. Dis. 25, jiae529 (2024).","journal-title":"J. Infect. Dis."},{"key":"55543_CR49","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137262","volume":"5","author":"N Obeng-Adjei","year":"2020","unstructured":"Obeng-Adjei, N. et al. Longitudinal analysis of naturally acquired PfEMP1 CIDR domain variant antibodies identifies associations with malaria protection. JCI Insight 5, e137262 (2020).","journal-title":"JCI Insight"},{"key":"55543_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.actatropica.2009.08.017","volume":"112","author":"NW Awah","year":"2009","unstructured":"Awah, N. W., Troye-Blomberg, M., Berzins, K. & Gysin, J. Mechanisms of malarial anaemia: potential involvement of the Plasmodium falciparum low molecular weight rhoptry-associated proteins. Acta Trop. 112, 295\u2013302 (2009).","journal-title":"Acta Trop."},{"key":"55543_CR51","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/imr.12807","volume":"293","author":"AR Jensen","year":"2020","unstructured":"Jensen, A. R., Adams, Y. & Hviid, L. Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it. Immunol. Rev. 293, 230\u2013252 (2020).","journal-title":"Immunol. Rev."},{"key":"55543_CR52","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/cid\/ciy1140","volume":"69","author":"B Mordmuller","year":"2019","unstructured":"Mordmuller, B. et al. First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria. Clin. Infect. Dis. 69, 1509\u20131516 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"55543_CR53","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1473-3099(19)30739-X","volume":"20","author":"SB Sirima","year":"2020","unstructured":"Sirima, S. B. et al. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. Lancet Infect. Dis. 20, 585\u2013597 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"55543_CR54","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.1248943","volume":"343","author":"CA Diebolder","year":"2014","unstructured":"Diebolder, C. A. et al. Complement is activated by IgG hexamers assembled at the cell surface. Science 343, 1260\u20131263 (2014).","journal-title":"Science"},{"key":"55543_CR55","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1473-3099(12)70055-5","volume":"12","author":"SM Taylor","year":"2012","unstructured":"Taylor, S. M., Parobek, C. M. & Fairhurst, R. M. Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect. Dis. 12, 457\u2013468 (2012).","journal-title":"Lancet Infect. Dis."},{"key":"55543_CR56","doi-asserted-by":"publisher","unstructured":"Lamptey, H. et al. Impact of haemoglobinopathies on asymptomatic Plasmodium falciparum infection and naturally acquired immunity among children in Northern Ghana. Front. Hematol. 2, https:\/\/doi.org\/10.3389\/frhem.2023.1150134 (2023).","DOI":"10.3389\/frhem.2023.1150134"},{"key":"55543_CR57","unstructured":"WHO. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Vitamin and Mineral Nutrition Information System. (ed. WHO\/NMH\/NHD\/MNM\/11.1) (World Health Organization, Geneva, 2011)."},{"key":"55543_CR58","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/cmi.12403","volume":"17","author":"L Stevenson","year":"2015","unstructured":"Stevenson, L. et al. Investigating the function of Fc-specific binding of IgM to Plasmodium falciparum erythrocyte membrane protein 1 mediating erythrocyte rosetting. Cell Microbiol. 17, 819\u2013831 (2015).","journal-title":"Cell Microbiol."},{"key":"55543_CR59","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1128\/cdli.2.1.30-34.1995","volume":"2","author":"M Theisen","year":"1995","unstructured":"Theisen, M., Vuust, J., Gottschau, A., Jepsen, S. & Hogh, B. Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli. Clin. Diagn. Lab Immunol. 2, 30\u201334 (1995).","journal-title":"Clin. Diagn. Lab Immunol."},{"key":"55543_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2023.107043","volume":"249","author":"B Londono-Renteria","year":"2024","unstructured":"Londono-Renteria, B. et al. Biomarker of Anopheles exposure in Ghanaian children with hemoglobin S and C. Acta Trop. 249, 107043 (2024).","journal-title":"Acta Trop."},{"key":"55543_CR61","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73080","volume":"10","author":"EA Kearney","year":"2021","unstructured":"Kearney, E. A. et al. Anopheles salivary antigens as serological biomarkers of vector exposure and malaria transmission: A systematic review with multilevel modelling. Elife 10, e73080 (2021).","journal-title":"Elife"},{"key":"55543_CR62","doi-asserted-by":"publisher","first-page":"e00136","DOI":"10.1128\/IAI.00136-18","volume":"86","author":"M Lopez-Perez","year":"2018","unstructured":"Lopez-Perez, M. et al. IgG responses to the Plasmodium falciparum antigen VAR2CSA in Colombia are restricted to pregnancy and are not induced by exposure to Plasmodium vivax. Infect. Immun. 86, e00136\u201300118 (2018).","journal-title":"Infect. Immun."},{"key":"55543_CR63","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/s41596-024-00963-7","volume":"19","author":"D Falck","year":"2024","unstructured":"Falck, D. & Wuhrer, M. GlYcoLISA: antigen-specific and subclass-specific IgG Fc glycosylation analysis based on an immunosorbent assay with an LC-MS readout. Nat. Protoc. 19, 1887\u20131909 (2024).","journal-title":"Nat. Protoc."},{"key":"55543_CR64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-0716-2189-9_5","volume":"2470","author":"M Lopez-Perez","year":"2022","unstructured":"Lopez-Perez, M. & Seidu, Z. Establishing and maintaining in vitro cultures of asexual blood stages of Plasmodium falciparum. Methods Mol. Biol. 2470, 37\u201349 (2022).","journal-title":"Methods Mol. Biol."},{"key":"55543_CR65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-0716-2189-9_7","volume":"2470","author":"M Lopez-Perez","year":"2022","unstructured":"Lopez-Perez, M. & Olsen, R. W. Immunomagnetic selection of Plasmodium falciparum-infected erythrocytes expressing particular PfEMP1 variants. Methods Mol. Biol. 2470, 69\u201378 (2022).","journal-title":"Methods Mol. Biol."},{"key":"55543_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-03975-w","volume":"20","author":"P Hedberg","year":"2021","unstructured":"Hedberg, P. et al. Red blood cell blood group A antigen level affects the ability of heparin and PfEMP1 antibodies to disrupt Plasmodium falciparum rosettes. Malar. J. 20, 441 (2021).","journal-title":"Malar. J."},{"key":"55543_CR67","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cellimm.2018.07.008","volume":"332","author":"MA Forrester","year":"2018","unstructured":"Forrester, M. A. et al. Similarities and differences in surface receptor expression by THP-1 monocytes and differentiated macrophages polarized using seven different conditioning regimens. Cell Immunol. 332, 58\u201376 (2018).","journal-title":"Cell Immunol."},{"key":"55543_CR68","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.3389\/fimmu.2018.02873","volume":"9","author":"KM Snyder","year":"2018","unstructured":"Snyder, K. M. et al. Expression of a recombinant high affinity IgG Fc receptor by engineered NK cells as a docking platform for therapeutic mAbs to target cancer cells. Front. Immunol. 9, 2873 (2018).","journal-title":"Front. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55543-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55543-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55543-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T13:02:12Z","timestamp":1735909332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55543-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["55543"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-55543-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4165378\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}